222 related articles for article (PubMed ID: 18296717)
21. Pim-1 kinase phosphorylates and stabilizes RUNX3 and alters its subcellular localization.
Kim HR; Oh BC; Choi JK; Bae SC
J Cell Biochem; 2008 Nov; 105(4):1048-58. PubMed ID: 18767071
[TBL] [Abstract][Full Text] [Related]
22. Type IV collagen induces STAT5 activation in MCF7 human breast cancer cells.
Robledo T; Arriaga-Pizano L; Lopez-Pérez M; Salazar EP
Matrix Biol; 2005 Oct; 24(7):469-77. PubMed ID: 16139998
[TBL] [Abstract][Full Text] [Related]
23. Roles of RUNX in B Cell Immortalisation.
West MJ; Farrell PJ
Adv Exp Med Biol; 2017; 962():283-298. PubMed ID: 28299664
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic gene silencing by Runx proteins.
Taniuchi I; Littman DR
Oncogene; 2004 May; 23(24):4341-5. PubMed ID: 15156191
[TBL] [Abstract][Full Text] [Related]
25. Regulation of gene expression in peripheral T cells by Runx transcription factors.
Djuretic IM; Cruz-Guilloty F; Rao A
Adv Immunol; 2009; 104():1-23. PubMed ID: 20457114
[TBL] [Abstract][Full Text] [Related]
26. Jab1/CSN5 induces the cytoplasmic localization and degradation of RUNX3.
Kim JH; Choi JK; Cinghu S; Jang JW; Lee YS; Li YH; Goh YM; Chi XZ; Lee KS; Wee H; Bae SC
J Cell Biochem; 2009 Jun; 107(3):557-65. PubMed ID: 19350572
[TBL] [Abstract][Full Text] [Related]
27. Functions of Runx in IgA class switch recombination.
Sugai M; Watanabe K; Nambu Y; Hayashi T; Shimizu A
J Cell Biochem; 2011 Feb; 112(2):409-14. PubMed ID: 21268061
[TBL] [Abstract][Full Text] [Related]
28. Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activity.
Page BD; Khoury H; Laister RC; Fletcher S; Vellozo M; Manzoli A; Yue P; Turkson J; Minden MD; Gunning PT
J Med Chem; 2012 Feb; 55(3):1047-55. PubMed ID: 22148584
[TBL] [Abstract][Full Text] [Related]
29. A reporter assay for Stat5-dependent promoters without cytokine stimulation.
Toda T; Wada H; Ogawa S; Tani-ichi S; Ikuta K
Anal Biochem; 2008 Jan; 372(2):250-2. PubMed ID: 17980692
[No Abstract] [Full Text] [Related]
30. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
[TBL] [Abstract][Full Text] [Related]
31. Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers.
Illendula A; Gilmour J; Grembecka J; Tirumala VSS; Boulton A; Kuntimaddi A; Schmidt C; Wang L; Pulikkan JA; Zong H; Parlak M; Kuscu C; Pickin A; Zhou Y; Gao Y; Mishra L; Adli M; Castilla LH; Rajewski RA; Janes KA; Guzman ML; Bonifer C; Bushweller JH
EBioMedicine; 2016 Jun; 8():117-131. PubMed ID: 27428424
[TBL] [Abstract][Full Text] [Related]
32. Covalent Modifications of RUNX Proteins: Structure Affects Function.
Blumenthal E; Greenblatt S; Huang G; Ando K; Xu Y; Nimer SD
Adv Exp Med Biol; 2017; 962():33-44. PubMed ID: 28299649
[TBL] [Abstract][Full Text] [Related]
33. The human CD6 gene is transcriptionally regulated by RUNX and Ets transcription factors in T cells.
Arman M; Aguilera-Montilla N; Mas V; Puig-Kröger A; Pignatelli M; Guigó R; Corbí AL; Lozano F
Mol Immunol; 2009 Jul; 46(11-12):2226-35. PubMed ID: 19446338
[TBL] [Abstract][Full Text] [Related]
34. Aurora kinase-induced phosphorylation excludes transcription factor RUNX from the chromatin to facilitate proper mitotic progression.
Chuang LS; Khor JM; Lai SK; Garg S; Krishnan V; Koh CG; Lee SH; Ito Y
Proc Natl Acad Sci U S A; 2016 Jun; 113(23):6490-5. PubMed ID: 27217562
[TBL] [Abstract][Full Text] [Related]
35. Selective expansion of genetically modified T cells using an antibody/interleukin-2 receptor chimera.
Sogo T; Kawahara M; Tsumoto K; Kumagai I; Ueda H; Nagamune T
J Immunol Methods; 2008 Aug; 337(1):16-23. PubMed ID: 18589435
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of RUNX genes in human esophageal squamous cell carcinoma: downregulation of RUNX3 worsens patient prognosis.
Tonomoto Y; Tachibana M; Dhar DK; Onoda T; Hata K; Ohnuma H; Tanaka T; Nagasue N
Oncology; 2007; 73(5-6):346-56. PubMed ID: 18500170
[TBL] [Abstract][Full Text] [Related]
37. Tracking STAT nuclear traffic.
Reich NC; Liu L
Nat Rev Immunol; 2006 Aug; 6(8):602-12. PubMed ID: 16868551
[TBL] [Abstract][Full Text] [Related]
38. Modulation of STAT5 interaction with LMW-PTP during early megakaryocyte differentiation.
Rigacci S; Guidotti V; Parri M; Berti A
Biochemistry; 2008 Feb; 47(6):1482-9. PubMed ID: 18197699
[TBL] [Abstract][Full Text] [Related]
39. Antagonistic interplay between ThPOK and Runx in lineage choice of thymocytes.
Egawa T; Taniuchi I
Blood Cells Mol Dis; 2009; 43(1):27-9. PubMed ID: 19375362
[TBL] [Abstract][Full Text] [Related]
40. An SH2 domain model of STAT5 in complex with phospho-peptides define "STAT5 Binding Signatures".
Gianti E; Zauhar RJ
J Comput Aided Mol Des; 2015 May; 29(5):451-70. PubMed ID: 25752764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
